Every published price is a first month
Injectable semaglutide, semaglutide tablets, injectable tirzepatide and tirzepatide tablets each carry a published figure, and each of those figures is explicitly a first-month price in SkinnyRx's own words.
No product page publishes the renewal rate. That is the single most important fact on this page, because a first-month figure tells you almost nothing about the cost of treatment. GLP-1 therapy is measured in months, not in one.
So the comparison a reader most wants to make cannot be made from SkinnyRx's site. You can compare its entry price against a rival's entry price. You cannot compare its ongoing cost against anything, because the ongoing cost is not published.
The scarcity framing, and what to do about it
The site-wide banner attaches a while-supplies-last line to the injectable figure. That is urgency language wrapped around a promotional rate, and it is worth naming for what it is.
It is not evidence of anything wrong with the medication or the seller. It is a reason to slow down rather than speed up, because the decision an urgency banner is pushing you toward is a subscription whose second month has no published price.
The fix is one question at intake: what does this cost in month two, and month six, in writing, before you pay for month one. If the answer will not come in writing, that is your answer.
Leaving early can cost you the discount
SkinnyRx's own language states that if you cancel a promotional plan early, any discounts received may be reversed or proportionally adjusted, and that the final refund may be less than the payment minus the unused portion.
Read that together with the first-month pricing and the shape becomes clear. The low entry price is attached to a plan, and stepping off the plan can retroactively unwind it.
That is not unusual in this category, but most sellers do not combine it with an unpublished renewal rate. Here you are agreeing to a plan whose ongoing price you have not seen and whose exit carries a clawback.
The disclosure that is genuinely good
SkinnyRx states its state exclusions in writing rather than leaving the question open, naming Alabama, Louisiana and Mississippi, and it blocks orders from them. Several sellers in this comparison publish nothing at all about where they operate.
It also says you are refunded in full, within a day or two, if a clinician decides you do not qualify. That removes the most common complaint about intake-first telehealth, which is paying before anyone has looked at you.
And it names its medical director on the semaglutide product page. Naming an accountable clinician is a small thing that a surprising number of sellers here will not do.
The pharmacy and the brand listings are both blanks
No compounding pharmacy is named anywhere on the site. The closest it gets is a category — licensed U.S. pharmacies, 503A pharmacies — which is a description rather than an identity.
For a compounded preparation the pharmacy is the manufacturer, so that is a real gap. Shed names three with street addresses in its Terms and Embody names four in its footer, which is the standard to hold this against.
The two FDA-approved products SkinnyRx lists are both badged Unavailable and carry no price. They are on the site, but a reader cannot buy either or price either, so they should not weigh in the decision.
SkinnyRx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $99/moCompounded injectable semaglutide, quoted verbatim as "$99 first month" on the product page beside "Compounded Injectable Semaglutide"; the site-wide banner reads "$99 GLP-1 Injections: While Supplies Last". The site does not publish the price for month two onward. | September 2026source |
| Semaglutide (compounded) | $149/moCompounded semaglutide tablets, quoted verbatim as "$149 first month" on the homepage product tile "Compounded Semaglutide Tablets — Once-daily tablet with semaglutide". The site does not publish the price for month two onward. | September 2026source |
| Tirzepatide (compounded) | $99/moCompounded injectable tirzepatide, quoted verbatim as "$99 first month" on the product page beside "Compounded Injectable Tirzepatide". The site does not publish the price for month two onward. | September 2026source |
| Tirzepatide (compounded) | $199/moCompounded tirzepatide tablets, quoted verbatim as "$199 first month" on the product page beside "Compounded Tirzepatide Tablets". The site does not publish the price for month two onward. | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 38 providers reviewed here are paid partners today; the other 34 are not. See how this works.
See SkinnyRx's current price →Good fit if
- Readers who want a price on every format — injectable and tablet, semaglutide and tirzepatide — without starting an intake first.
- Buyers in Alabama, Louisiana or Mississippi who would rather be told no up front than discover it at checkout, since SkinnyRx publishes and enforces those exclusions.
- People who want a refund guarantee if a clinician turns them down, which SkinnyRx states plainly with a stated turnaround.
- Patients who want an accountable clinician named on the product page rather than an anonymous medical group.
Look elsewhere if
- Anyone budgeting past month one. Every SkinnyRx figure is a first-month rate and no product page publishes the renewal price.
- Readers who need the compounding pharmacy named. Shed names three with street addresses and Embody names four with addresses and phone numbers.
- Anyone who may want to stop early, since cancelling a promotional plan can reverse or adjust the discount and shrink the refund.
- Buyers who actually want an FDA-approved product. SkinnyRx lists two and badges both unavailable with no price; Eden and Shed sell approved brands at published figures.
How this review was verified
- Read all four SkinnyRx product listings at their source URLs and logged each published figure with the date read.
- Quoted SkinnyRx's own first-month wording into the qualifier on every one of the four figures, so no first-month rate can travel into a comparison table as an ongoing monthly price.
- Recorded on each figure that the price for month two onward is not published, having looked for it on the product pages themselves.
- Logged the site-wide banner language, including the while-supplies-last framing attached to the injectable figure.
- Read the cancellation and refund language and quoted the discount-reversal clause verbatim.
- Read the state-availability statement and recorded the three excluded states SkinnyRx names.
- Searched the site for a named compounding pharmacy and recorded the category language it uses instead.
- Recorded that both FDA-approved listings are badged Unavailable and carry no price, so brand availability is never overstated.